Letters NICE on hypertension

Don’t β blockers still have a role in hypertension?

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6495 (Published 12 October 2011) Cite this as: BMJ 2011;343:d6495
  1. John M Cruickshank, cardiologist1
  1. 1Long Melford, Suffolk CO10 9DE, UK
  1. johndtl{at}aol.com

The advice on the firstline treatment of younger and middle aged hypertensive patients with either an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker, with no mention of β blockade, is worrying.1

Only one randomised study with hard end points has compared ACE inhibitors and β blockers.2 After 9-10 years of follow-up the trends in the reduction of all seven …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe